Table 8.6g

Immunosuppression Use for Maintenance Between Discharge

and One Year Following Transplantation, 1994 to 2003

Recipients with Kidney-Pancreas Transplants

  Year of Transplant
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
Transplants 748 919 861 853 972 943 914 891 905 870
Tx with Follow-up Immunosuppression Info 649 825 775 781 870 861 840 818 823 775
Corticosteroids Any in Category 98.9% 99.9% 100.0% 99.9% 99.7% 99.5% 95.6% 93.4% 89.4% 81.7%
Steroids 98.9% 99.9% 100.0% 99.9% 99.7% 99.5% 95.6% 93.4% 89.4% 81.7%
Cyclosporine Any in Category 83.4% 67.4% 61.8% 48.7% 36.2% 31.0% 23.0% 17.0% 13.5% 11.7%
Cyclosporin 81.7% 33.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0%
Sandimmmune 1.7% 16.1% 12.9% 8.6% 4.1% 5.0% 3.0% 1.8% 1.3% 0.6%
Neoral 0.0% 17.5% 48.9% 40.1% 32.1% 25.8% 18.8% 12.2% 8.9% 9.2%
Gengraf 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 1.2% 2.8% 3.2% 1.9%
Eon 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0%
Tacrolimus Any in Category 27.7% 46.8% 50.8% 62.4% 75.3% 80.7% 84.3% 89.4% 89.8% 87.6%
Tacrolimus 27.7% 46.8% 50.8% 62.4% 75.3% 80.7% 84.3% 89.4% 89.8% 87.6%
Antimetabolites Any in Category 93.2% 89.2% 94.1% 96.2% 96.8% 95.7% 87.6% 80.4% 82.3% 82.3%
Mycophenolate Mofetil 0.3% 31.2% 72.1% 82.2% 85.1% 87.5% 81.3% 77.5% 79.8% 80.3%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Azathioprine 92.8% 57.8% 21.9% 14.0% 11.7% 8.2% 6.3% 2.9% 2.4% 2.1%
Cytoxan 0.2% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.0% 0.0% 0.0% 0.1% 2.0% 5.2% 21.0% 31.2% 27.6% 27.6%
Sirolimus 0.0% 0.0% 0.0% 0.1% 0.9% 4.8% 20.6% 31.1% 27.6% 27.6%
Everolimus 0.0% 0.0% 0.0% 0.0% 1.0% 0.5% 0.4% 0.1% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 2, 2005.

Percentages are calculated based on the total number of patients with any immunosuppression use between discharge and one year following transplantation.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug withinthe same category.